vs
PALVELLA THERAPEUTICS, INC.（PVLA）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
Arcadia Biosciences, Inc.的季度营收约是PALVELLA THERAPEUTICS, INC.的1.7倍（$901.0K vs $520.0K），PALVELLA THERAPEUTICS, INC.同比增速更快（14.3% vs -25.8%），过去两年Arcadia Biosciences, Inc.的营收复合增速更高（-4.5% vs -36.7%）
Palvella Therapeutics是一家临床阶段生物制药企业，专注于开发针对罕见、致残性遗传病的靶向疗法，服务存在高度未满足医疗需求的全球患者群体，核心在研管线覆盖多种暂无有效治疗方案的先天性疾病。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
PVLA vs RKDA — 直观对比
营收规模更大
RKDA
是对方的1.7倍
$520.0K
营收增速更快
PVLA
高出40.1%
-25.8%
两年增速更快
RKDA
近两年复合增速
-36.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $520.0K | $901.0K |
| 净利润 | — | $-1.3M |
| 毛利率 | — | 21.4% |
| 营业利润率 | — | -152.8% |
| 净利率 | — | -148.3% |
| 营收同比 | 14.3% | -25.8% |
| 净利润同比 | -221.8% | 67.1% |
| 每股收益（稀释后） | — | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PVLARKDA
| Q4 25 | $520.0K | $901.0K | ||
| Q3 25 | $628.0K | $1.3M | ||
| Q2 25 | $690.0K | $1.5M | ||
| Q1 25 | $752.0K | $1.2M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | $0 | $1.5M | ||
| Q2 24 | $0 | $1.3M | ||
| Q1 24 | $53.0K | $987.0K |
净利润PVLARKDA
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $-11.3M | $856.0K | ||
| Q2 25 | $-9.5M | $-4.5M | ||
| Q1 25 | $-8.2M | $2.6M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $-6.8M | $-1.6M | ||
| Q2 24 | $-4.2M | $1.1M | ||
| Q1 24 | $-2.5M | $-2.4M |
毛利率PVLARKDA
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 31.9% | ||
| Q3 24 | — | 32.9% | ||
| Q2 24 | — | 51.5% | ||
| Q1 24 | — | 52.3% |
营业利润率PVLARKDA
| Q4 25 | — | -152.8% | ||
| Q3 25 | -1620.5% | -88.5% | ||
| Q2 25 | -1340.6% | -34.4% | ||
| Q1 25 | -1046.7% | 44.2% | ||
| Q4 24 | — | -187.7% | ||
| Q3 24 | — | -114.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | -3318.9% | -160.9% |
净利率PVLARKDA
| Q4 25 | — | -148.3% | ||
| Q3 25 | -1806.5% | 65.7% | ||
| Q2 25 | -1372.6% | -306.4% | ||
| Q1 25 | -1088.4% | 216.6% | ||
| Q4 24 | — | -334.5% | ||
| Q3 24 | — | -104.9% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | -4784.9% | -245.5% |
每股收益（稀释后）PVLARKDA
| Q4 25 | — | $-0.97 | ||
| Q3 25 | $-1.03 | $0.62 | ||
| Q2 25 | $-0.86 | $-3.26 | ||
| Q1 25 | $-0.74 | $1.90 | ||
| Q4 24 | — | $-2.99 | ||
| Q3 24 | $-3.94 | $-1.18 | ||
| Q2 24 | $-2.47 | $0.78 | ||
| Q1 24 | $-1.54 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $58.0M | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $28.0M | $4.1M |
| 总资产 | $59.6M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PVLARKDA
| Q4 25 | $58.0M | $4.6M | ||
| Q3 25 | $63.6M | $5.9M | ||
| Q2 25 | $70.4M | $4.4M | ||
| Q1 25 | $75.6M | $3.2M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | $19.4M | $6.6M | ||
| Q2 24 | $19.7M | $8.1M | ||
| Q1 24 | $19.1M | $8.5M |
股东权益PVLARKDA
| Q4 25 | $28.0M | $4.1M | ||
| Q3 25 | $38.7M | $5.4M | ||
| Q2 25 | $47.8M | $4.5M | ||
| Q1 25 | $55.6M | $8.9M | ||
| Q4 24 | — | $6.2M | ||
| Q3 24 | $-87.4M | $10.3M | ||
| Q2 24 | $-80.8M | $11.7M | ||
| Q1 24 | $-76.9M | $10.6M |
总资产PVLARKDA
| Q4 25 | $59.6M | $6.5M | ||
| Q3 25 | $66.9M | $8.6M | ||
| Q2 25 | $73.7M | $7.8M | ||
| Q1 25 | $79.4M | $13.0M | ||
| Q4 24 | — | $13.5M | ||
| Q3 24 | $20.5M | $15.2M | ||
| Q2 24 | $25.1M | $17.4M | ||
| Q1 24 | $29.5M | $16.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-25.0M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PVLARKDA
| Q4 25 | $-25.0M | $-861.0K | ||
| Q3 25 | $-7.9M | $-257.0K | ||
| Q2 25 | $-5.4M | $-2.0M | ||
| Q1 25 | $-6.8M | $-1.6M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $-2.7M | $-1.8M | ||
| Q2 24 | $-1.6M | $-2.5M | ||
| Q1 24 | $-1.1M | $-3.2M |
自由现金流PVLARKDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-2.5M | ||
| Q1 24 | — | $-3.2M |
自由现金流率PVLARKDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -188.3% | ||
| Q1 24 | — | -326.5% |
资本支出强度PVLARKDA
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | 0.0% | 1.3% |
现金转化率PVLARKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
